SHELLEY TRIPLETT: Open Payments
NPI 1972160778 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,005 in 93 payments from 19 companies in 2025. Trend: 2023 $2,498 · 2024 $1,614 · 2025 $2,005
Food & beverage: $2,005
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $438 |
| AstraZeneca Pharmaceuticals LP | 11 | $266 |
| Novo Nordisk Inc | 18 | $230 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $175 |
| ABBVIE INC. | 9 | $156 |
| PFIZER INC. | 8 | $154 |
| Axsome Therapeutics, Inc. | 5 | $107 |
| Dexcom, Inc. | 3 | $77 |
| Janssen Pharmaceuticals, Inc | 4 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
Products named: ZEPBOUND, MOUNJARO, FARXIGA, Kerendia, NURTEC ODT, Ozempic, Auvelity, AIRSUPRA.
Industry payments across OK — which companies pay providers there.
